ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Kuo Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4557-4086; OpenAlex author ID A5029204275. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4. Co-author DOI 10.1186/s41065-023-00280-1 ↗
[Prognostic value of tumor infiltration immune cells in pancreatic cancer]. Co-author DOI 10.3760/cma.j.issn.0529-5815.2018.06.015 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pengfei Liu · 1 shared paper, 2023 · strength 0.16
- Paper EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4. DOI 10.1186/s41065-023-00280-1 ↗
Hongfeng Li · 1 shared paper, 2023 · strength 0.16
- Paper EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4. DOI 10.1186/s41065-023-00280-1 ↗
Jianqi Hao · 1 shared paper, 2018 · strength 0.12
- Paper [Prognostic value of tumor infiltration immune cells in pancreatic cancer]. DOI 10.3760/cma.j.issn.0529-5815.2018.06.015 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.